Meghan Lovegren is approaching 20 years of experience in clinical research. Prior to joining Biohaven, Meghan managed clinical studies in genetic diseases (Duchenne Muscular Dystrophy) and virology (HBV and HCV) at Bristol-Myers Squibb for 12 years.
Currently, there are no issues on this topic.